0,824  0,008  Caspase 9 stimulant
0,810  0,008  Antineoplastic (lung cancer)
0,796  0,009  Antineoplastic (breast cancer)
0,768  0,009  Antineoplastic (colorectal cancer)
0,739  0,007  Prostate cancer treatment
0,741  0,015  CYP3A4 substrate
0,721  0,004  Tubulin antagonist
0,714  0,028  Apoptosis agonist
0,685  0,015  Antineoplastic (colon cancer)
0,654  0,005  Antimitotic
0,639  0,009  NOS2 expression inhibitor
0,637  0,010  UGT1A9 substrate
0,612  0,003  Alpha tubulin antagonist
0,600  0,025  TNF expression inhibitor
0,574  0,014  Antineoplastic (pancreatic cancer)
0,556  0,005  UGT2B4 substrate
0,579  0,034  Transcription factor NF kappa B inhibitor
0,596  0,054  Antiinflammatory
0,542  0,004  Beta tubulin antagonist
0,551  0,020  Antineoplastic (ovarian cancer)
0,547  0,018  Antineoplastic (melanoma)
0,549  0,021  Vasodilator, peripheral
0,553  0,025  Aldehyde oxidase inhibitor
0,556  0,030  Antileukemic
0,525  0,006  Antineoplastic (squamous cell carcinoma)
0,532  0,016  Caspase 3 stimulant
0,530  0,023  Antihypercholesterolemic
0,508  0,011  Antineoplastic (lymphoma)
0,506  0,010  RNA-directed DNA polymerase inhibitor
0,514  0,021  Antineoplastic (cervical cancer)
0,494  0,007  Hepatoprotectant
0,501  0,016  Nitric oxide antagonist
0,506  0,021  Hepatic disorders treatment
0,497  0,022  CTGF expression inhibitor
0,490  0,020  Chemopreventive
0,474  0,023  Antioxidant
0,474  0,023  Cytostatic
0,475  0,028  Cytotoxic
0,457  0,010  Antineoplastic (carcinoma)
0,456  0,011  P-glycoprotein inhibitor
0,471  0,032  CYP2C19 substrate
0,475  0,041  Antipruritic, allergic
0,462  0,033  Ulceration
0,446  0,025  Cardiovascular analeptic
0,442  0,025  ICAM1 expression inhibitor
0,431  0,017  UDP-glucuronosyltransferase substrate
0,435  0,030  Antineoplastic (glioma)
0,421  0,018  Calcium channel activator
0,429  0,027  Antineoplastic (non-small cell lung cancer)
0,420  0,020  Antineoplastic (renal cancer)
0,444  0,049  Immunosuppressant
0,403  0,008  UGT2B15 substrate
0,431  0,040  Teratogen
0,427  0,040  Respiratory analeptic
0,418  0,035  AR expression inhibitor
0,398  0,016  Antimutagenic
0,413  0,034  Lipoxygenase inhibitor
0,387  0,010  Pneumotoxic
0,401  0,024  UGT1A6 substrate
0,387  0,012  UGT1A3 substrate
0,386  0,013  UGT2B7 substrate
0,404  0,031  Antineoplastic (multiple myeloma)
0,400  0,028  Antineoplastic (glioblastoma multiforme)
0,389  0,020  Sodium/bile acid cotransporter inhibitor
0,405  0,037  Apoptosis antagonist
0,382  0,017  UGT1A4 substrate
0,389  0,031  Free radical scavenger
0,375  0,020  UGT1A1 substrate
0,384  0,032  Proliferative diseases treatment
0,420  0,068  Antibacterial
0,370  0,020  Antineoplastic (sarcoma)
0,348  0,003  UGT2B10 substrate
0,350  0,013  Lipid peroxidase inhibitor
0,375  0,045  Embryotoxic
0,370  0,047  Spasmolytic
0,341  0,021  Antiviral (Influenza)
0,339  0,020  Contraceptive
0,336  0,017  VCAM1 expression inhibitor
0,347  0,030  Antineoplastic (lymphocytic leukemia)
0,343  0,026  GST M1-1 substrate
0,342  0,027  Abortion inducer
0,335  0,021  Antihypotensive
0,351  0,043  Sensitization
0,356  0,051  NOS3 expression inhibitor
0,355  0,053  Vasodilator, coronary
0,346  0,046  Hypoxia-inducible factor 1 alpha inhibitor
0,340  0,043  Antipyretic
0,338  0,041  Hypoglycemic
0,324  0,027  Muscle relaxant
0,308  0,012  Acetylcholinesterase inhibitor
0,327  0,032  Antihypertriglyceridemic
0,310  0,016  Genotoxic
0,314  0,020  Antipruritic, non-allergic
0,346  0,053  Cardioprotectant
0,344  0,053  Analeptic
0,337  0,047  Chemoprotective
0,335  0,047  Antineoplastic (osteosarcoma)
0,392  0,110  Antineoplastic (solid tumors)
0,311  0,030  Antiviral (HIV)
0,381  0,102  Cyclophilin D inhibitor
0,381  0,102  Antidiabetic
0,293  0,019  Amylase inhibitor
0,331  0,059  Antineoplastic (brain cancer)
0,283  0,013  UGT2B9 substrate
0,336  0,066  Antifungal
0,349  0,081  CYP2C9 substrate
0,310  0,045  Vascular (periferal) disease treatment
0,335  0,071  Cholesterol antagonist
0,268  0,005  Microtubule formation inhibitor
0,305  0,042  5 Hydroxytryptamine uptake stimulant
0,301  0,043  Antiulcerative
0,281  0,024  Melanin inhibitor
0,281  0,024  Neurotrophic factor enhancer
0,304  0,050  Antidiabetic symptomatic
0,270  0,024  Cholinergic
0,309  0,068  Antineoplastic (small cell lung cancer)
0,245  0,007  Arachidonic acid antagonist
0,262  0,026  Antineoplastic (gastric cancer)
0,255  0,019  Antineoplastic (bone cancer)
0,331  0,095  GST A substrate
0,287  0,051  Antineoplastic (bladder cancer)
0,260  0,027  Interferon gamma antagonist
0,292  0,060  DNA damaging
0,279  0,062  Tumour necrosis factor alpha release inhibitor
0,300  0,088  Antithrombotic
0,240  0,029  Protein kinase stimulant
0,283  0,075  5 Hydroxytryptamine release stimulant
0,297  0,089  FMO1 substrate
0,344  0,139  Alpha-glucosidase inhibitor
0,263  0,058  Cyclic AMP phosphodiesterase inhibitor
0,206  0,004  UGT2B11 substrate
0,227  0,034  LDLR expression enhancer
0,211  0,019  Antineoplastic antibiotic
0,249  0,058  Amyloid beta aggregation inhibitor
0,227  0,038  Antiviral (Herpes)
0,214  0,025  GST P1-1 substrate
0,268  0,081  Lipoprotein disorders treatment
0,256  0,069  Antineoplastic (liver cancer)
0,216  0,030  Topoisomerase II inhibitor
0,205  0,019  Expectorant
0,252  0,066  Tyrosine 3 hydroxylase inhibitor
0,250  0,069  Vasodilator
0,248  0,068  Hypolipemic
0,248  0,069  Cardiodepressant
0,209  0,034  Heat shock protein 90 antagonist
0,192  0,019  Choleretic
0,261  0,090  CYP1A2 substrate
0,188  0,020  Adenylate cyclase stimulant
0,198  0,032  Antifungal enhancer
0,193  0,028  Cholesterol synthesis inhibitor
0,189  0,025  Antihemorrhagic
0,221  0,059  Nitric-oxide synthase stimulant
0,201  0,042  Toxic, respiratory center
0,177  0,020  Sulfotransferase substrate
0,218  0,062  Mutagenic
0,232  0,082  Antiprotozoal (Leishmania)
0,179  0,030  Cystathionine beta-synthase inhibitor
0,175  0,030  Cyclooxygenase 3 inhibitor
0,268  0,123  Antineoplastic (endocrine cancer)
0,228  0,085  DNA synthesis inhibitor
0,191  0,048  Antiviral (Influenza A)
0,211  0,069  Anesthetic general
0,199  0,057  Lipocortins synthesis antagonist
0,165  0,024  UGT2B1 substrate
0,161  0,022  Antiviral (Influenza B)
0,183  0,046  Skeletal muscle relaxant
0,205  0,068  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,197  0,061  VEGF expression inhibitor
0,204  0,068  Carcinogenic
0,166  0,031  Chelator
0,172  0,038  Toll-Like receptor 2 antagonist
0,174  0,044  Antiseptic
0,178  0,049  Carcinogenic, group 1
0,148  0,019  Anabolic
0,276  0,149  CYP2C19 inhibitor
0,152  0,027  Antineoplastic alkaloid
0,154  0,030  Mucolytic
0,154  0,030  Antineoplastic (uterine cancer)
0,153  0,031  Contraceptive female
0,159  0,038  Topoisomerase I inhibitor
0,139  0,019  SULT1E1 substrate
0,142  0,024  Topoisomerase II alpha inhibitor
0,182  0,064  Antirickettsial
0,233  0,116  CYP2D6 substrate
0,181  0,067  Succinate dehydrogenase inhibitor
0,152  0,038  Ca2+-transporting ATPase inhibitor
0,160  0,047  Cocaine dependence treatment
0,224  0,112  Antidiabetic (type 2)
0,189  0,077  Platelet adhesion inhibitor
0,146  0,034  Photosensitizer
0,146  0,037  SULT1A1 substrate
0,123  0,016  Glycine receptor antagonist
0,154  0,052  Skin whitener
0,127  0,025  Antibiotic
0,134  0,033  Estrogen antagonist
0,153  0,052  Antieczematic
0,135  0,036  Antifungal (Pneumocystis)
0,118  0,021  ATPase (Vacuolar H+) inhibitor
0,105  0,007  SULT2A1 substrate
0,106  0,009  Topoisomerase II beta inhibitor
0,119  0,022  Keratolytic
0,141  0,044  Glutathione S-transferase substrate
0,101  0,006  Postcoital contraceptive
0,155  0,060  SULT1A3 substrate
0,206  0,111  Superoxide dismutase inhibitor
0,166  0,076  ATPase inhibitor
0,140  0,050  Vanilloid 1 agonist
0,110  0,022  Dopamine D1 antagonist
0,246  0,158  Histamine release inhibitor
0,160  0,074  Uterine stimulant
0,110  0,027  Contraceptive male
0,192  0,110  Peptidyltransferase inhibitor
0,105  0,024  HIV-1 integrase (3'-Processing) inhibitor
0,184  0,103  Angiogenesis stimulant
0,090  0,010  Estrogen receptor alpha agonist
0,143  0,066  Anesthetic
0,095  0,018  Estrogen agonist
0,101  0,026  Estrogen receptor alpha antagonist
0,122  0,047  Multidrug resistance-associated protein 1 inhibitor
0,090  0,015  Heat shock protein 90 beta antagonist
0,148  0,074  NOS3 expression enhancer
0,090  0,016  Protein 50S ribosomal subunit inhibitor
0,078  0,003  Leukotriene B4 receptor 2 antagonist
0,175  0,101  Platelet aggregation inhibitor
0,131  0,058  Alkylator
0,096  0,024  HIV-1 integrase (Strand Transfer) inhibitor
0,113  0,041  Estrogen receptor beta antagonist
0,110  0,039  Androgen antagonist
0,099  0,028  CDC25A inhibitor
0,148  0,079  CF transmembrane conductance regulator agonist
0,141  0,077  Antiprotozoal (Coccidial)
0,081  0,017  Transcription factor RelA inhibitor
0,116  0,052  Electron transport complex I inhibitor
0,117  0,054  Acetylcholine release stimulant
0,100  0,039  Antiviral (Trachoma)
0,266  0,206  5 Hydroxytryptamine release inhibitor
0,082  0,023  Androgen agonist
0,200  0,142  Antiischemic
0,163  0,105  Psychostimulant
0,112  0,056  Antiprotozoal (Toxoplasma)
0,074  0,018  Lipocortins synthesis agonist
0,090  0,034  Narcotic antagonist
0,140  0,085  Antidiarrheal
0,101  0,045  Actinic keratosis treatment
0,060  0,005  Leukotriene B4 receptor 1 antagonist
0,081  0,027  Aromatase inhibitor
0,086  0,032  Glycine receptor agonist
0,138  0,085  Antidote
0,171  0,119  Antineoplastic enhancer
0,120  0,069  Growth stimulant
0,118  0,066  Constipation treatment
0,108  0,058  5-Lipoxygenase inhibitor
0,090  0,040  Antiviral (Dengue virus)
0,090  0,041  Na+ K+ transporting ATPase inhibitor
0,084  0,034  Antitreponemal
0,152  0,103  Sedative
0,192  0,145  Transcription factor STAT3 inhibitor
0,052  0,007  Tubulin agonist
0,067  0,022  Ryanodine receptor antagonist
0,197  0,153  Antimycobacterial
0,134  0,089  Pregnane X receptor agonist
0,095  0,052  Alpha 2 adrenoreceptor antagonist
0,070  0,027  Aldose reductase inhibitor
0,127  0,085  Antiparkinsonian, tremor relieving
0,135  0,096  Heat shock protein 70 antagonist
0,092  0,053  Ornithine decarboxylase inhibitor
0,070  0,032  Antimycoplasmal
0,161  0,124  Antiparkinsonian, rigidity relieving
0,134  0,098  Sigma receptor agonist
0,147  0,112  Phospholipase C inhibitor
0,063  0,030  Postmenopausal disorders treatment
0,119  0,087  Interleukin 4 antagonist
0,118  0,086  NADPH oxidase inhibitor
0,111  0,079  M18 aspartyl aminopeptidase inhibitor
0,192  0,161  12-Lipoxygenase inhibitor
0,114  0,083  Coagulant
0,043  0,012  HMG CoA reductase inhibitor
0,091  0,061  Paget's disease treatment
0,086  0,056  Vanilloid agonist
0,155  0,125  CYP2B6 inhibitor
0,078  0,048  SULT1A2 substrate
0,074  0,047  Histidine decarboxylase inhibitor
0,046  0,020  Progesterone antagonist
0,081  0,054  Xanthine oxidase substrate
0,098  0,072  AMP-activated protein kinase stimulant
0,069  0,044  Andropause treatment
0,105  0,080  DNA polymerase I inhibitor
0,049  0,025  Estradiol 17 beta-dehydrogenase inhibitor
0,065  0,041  Calcium channel P-type blocker
0,085  0,062  Granulocyte macrophage colony stimulating factor agonist
0,082  0,059  Estrogen-related receptor beta agonist
0,094  0,071  Alpha 2c adrenoreceptor antagonist
0,031  0,008  Dopamine D1 agonist
0,098  0,077  Alpha 2b adrenoreceptor antagonist
0,163  0,142  Acute neurologic disorders treatment
0,171  0,152  Radioprotector
0,115  0,097  Papain-like protease (SARS coronavirus) inhibitor
0,090  0,074  Dementia treatment
0,124  0,108  Eye irritation, high
0,087  0,073  Vascular dementia treatment
0,051  0,037  Glucose-6-phosphate translocase inhibitor
0,036  0,022  Estrogen receptor beta agonist
0,064  0,051  Hypercalcemia treatment
0,062  0,050  Dopamine agonist
0,085  0,073  Prolactin inhibitor
0,130  0,118  Prostate disorders treatment
0,021  0,010  Progesterone receptor B antagonist
0,039  0,029  Cathepsin L2 inhibitor
0,055  0,045  Pregnane X receptor antagonist
0,202  0,193  Stroke treatment
0,183  0,175  Gastrin inhibitor
0,048  0,042  Anesthetic inhalation
0,019  0,013  Antibiotic Anthracycline-like
0,047  0,042  Factor III inhibitor
0,037  0,032  Dopamine D5 agonist
0,067  0,062  Alpha 2a adrenoreceptor antagonist
0,173  0,169  Radiosensitizer
0,042  0,038  Microtubule stabilization
0,087  0,083  Bile acid receptor antagonist
0,105  0,101  Antihyperlipoproteinemic
0,028  0,025  Prostaglandin D2 agonist
0,089  0,086  Glutamate (mGluR7) agonist
0,104  0,102  Alcohol dehydrogenase substrate
0,162  0,161  Antiosteoporotic
0,025  0,024  RNA-directed RNA polymerase stimulant
0,048  0,047  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor

